Benoxaprofen Glucuronide (CAS 67472-42-8)

Benoxaprofen Glucuronide, a metabolite of the parent compound benoxaprofen, plays a significant role in understanding the pharmacokinetics and metabolic pathways of nonsteroidal anti-inflammatory compounds in research environments. As a conjugate where benoxaprofen is linked to glucuronic acid, this compound is primarily formed in the liver through the enzymatic process of glucuronidation, a key phase II drug metabolism reaction which enhances the solubility of hydrophobic molecules and facilitates their excretion. In scientific studies, Benoxaprofen Glucuronide serves as a crucial marker to investigate the efficiency and pathways of glucuronidation reactions in different species, thereby providing insights into interspecies differences and potential xenobiotic interactions. Researchers leverage this compound to explore the dynamics of drug clearance and to assess the impact of metabolic stability on the excretion profiles of pharmaceutical substances. By studying Benoxaprofen Glucuronide, scientists can better understand how modifications in molecular structure influence metabolic pathways, which is essential for the design and development of safer and more effective molecules. This research is invaluable in the field of toxicology and pharmacology, where understanding the metabolic fate of chemicals is crucial for predicting their behavior in biological systems.